From Disruption to Agility: Resilient Strategies for Medtech in a Shifting Global Order

Amanda Klingler – Partner, King & Spalding

Amanda Klingler is a partner in the firm’s Washington, D.C. and Chicago offices with more than 10 years of experience advising life science clients.  As a partner in the firm’s FDA and Life Sciences practice, Amanda advises pharmaceutical, medical device and biotech companies and pharmacies, on a wide range of regulatory matters, enforcement actions, civil litigation, investigations, product liability litigation, and compliance counseling. As a co-leader of the firm’s AI/ML Tactical Operations team, Amanda also frequently advises clients on the use of AI/ML during the life cycle of drugs and medical devices, including digital health products. 

Mark Sentenac – Partner, King & Spalding

Mark Sentenac is a partner with King & Spalding’s Trial and Global Disputes. Mark’s practice focuses on representing pharmaceutical and medical device manufacturers in complex products liability litigation throughout the country, including in federal multidistrict litigation and state coordinated proceedings. He has experience in all phases of litigation, including trials, taking depositions, working with subject matter experts in complex scientific fields, coordinating large-scale electronic discovery and drafting dispositive, pre-trial and appellate briefs. In his practice, Mark has assisted in advising companies in all aspects of product safety, including on risk assessments, government investigations, product recalls and indemnity issues.

Micha Nandaraj Gallo – Senior Associate, King & Spalding

Micha Nandaraj Gallo defends clients facing high stakes, complex litigations and investigations across a wide range of industries including pharma, tech, automotives, and sports. Micha routinely serves on a team of National Coordinating Counsel that manage uniform and consistent strategic defenses across multiple federal and state court proceedings. In addition to her litigation work, Micha also advises companies on emerging product liability risks and trends such as the use of artificial intelligence and machine learning in the development and production of consumer products.

Simran Modi – Associate, King & Spalding

Simran is an associate in King & Spalding’s Atlanta office and is a member of the Trial & Global Disputes practice group. Simran’s practice focuses on representing businesses in high-stakes commercial litigation, complex business disputes, and product liability litigation. She is a team member on several matters, including representation for Fortune 500 companies such as Coca-Cola, R.J. Reynolds, and Boehringer Ingelheim.